Fulgar, an Italian manufacturer and distributor of elastic and covered spandex yarns, and the Rhodia-Solvay Group have collaborated to develop Q-Skin powered by Amni Virus-Bac Off yarn with antiviral and antibacterial properties.

Developed in record time by the Rhodia-Solvay research laboratories in Paulínia and Santo Andre, Brazil, this extraordinary polyamide yarn acts against bacterial growth and virus transmission. These properties are the result of antiviral and anti-bacterial agent permanently incorporated into the polymer matrix.

Electrical affinity with the proteins present in the external structure of the virus enables this agent to prevent the fabric from becoming a host surface enabling the spread of the harmful viruses and bacteria and reducing the risk and speed of contamination. The yarn’s antiviral properties have been tested by an independent laboratory in line with the international textile protocols set out by ISO 18184 standards regarding the determination of the anitiviral activity of textiles.

The lingering threat posed by COVID-19, alongwith the return to offices and schools has created an exponentially rising demand for garments given anti-bacterial and antiviral protection treatments. Many manufacturing companies in Italy and the rest of Europe are prioritizing such products.